@christine.lovly , Division Chief, Thoracic Medical Oncology, City of Hope National Medical Center, is on the front lines of treatment for people with ALK+ lung cancer, working hard to propel the field forward and create better outcomes for patients.

She is a leading authority on why tumors become resistant to targeted therapies, research supported by ALK+ Positive. Her dream reaches past a cure, to a world where no one has to endure this disease. Thank you, Dr. Lovly, on everything you're doing to make our dream of a cure possible. #MoreResearchMoreDreams #LCAM @cityofhope